Summit Financial Group, Inc. Q2 2023 vs. Q3 2023 13F Holdings Comparison

Microsoft Corp, Procter and Gamble Co, and Johnson & Johnson: A Closer Look at Summit Financial Group's Q2 and Q3 2023 Holdings

In the ever-changing world of investments, it's essential for financial institutions to stay on top of their holdings and make strategic decisions based on the latest data. Summit Financial Group, Inc., a renowned investment management company, recently released its Q2 and Q3 2023 13F holdings comparison. This comparison provides valuable insights into the changes in their holdings and sheds light on their investment strategies during this period.

One of the most notable changes in Summit Financial Group's holdings is its position in Microsoft Corp (MSFT). In Q2 2023, the company held 30,745 shares of Microsoft, which decreased slightly to 30,305 shares in Q3 2023. The value of their Microsoft holdings also saw a decline from $10,469,000 in Q2 to $9,568,000 in Q3, representing an 8.6% decrease. Despite the decrease, Microsoft remains a significant part of Summit Financial Group's portfolio.

Another noteworthy adjustment in Summit Financial Group's holdings is their position in Procter and Gamble Co (PG). In Q2 2023, Summit Financial Group held 43,595 shares of Procter and Gamble, which declined to 42,980 shares in Q3 2023. The value of their Procter and Gamble holdings decreased from $6,615,000 to $6,269,000, reflecting a 5.2% decrease. This change suggests a tactical shift in their investment strategy.

Summit Financial Group also made adjustments to their holdings in Johnson & Johnson (JNJ). In Q2 2023, they held 38,081 shares of the company, which decreased to 37,263 shares in Q3 2023. The value of their Johnson & Johnson holdings dropped from $6,303,000 to $5,803,000, representing a 7.9% decrease. This change may indicate a reaction to market conditions or a strategic decision to reallocate their holdings.

While some holdings experienced a decrease, Summit Financial Group's position in Lilly Eli & Co (LLY) bucked the trend. In Q2 2023, they held 11,565 shares of the company, which remained almost unchanged at 11,563 shares in Q3 2023. However, the value of their Lilly Eli holdings saw a significant increase from $5,423,000 in Q2 to $6,210,000 in Q3, representing a remarkable 14.5% growth. This change suggests a positive outlook on the pharmaceutical industry and highlights Summit Financial Group's confidence in the company's performance.

It is also worth mentioning Summit Financial Group's position in Exxon Mobil Corp (XOM). In Q2 2023, they held 45,359 shares of Exxon Mobil, which increased to 49,361 shares in Q3 2023. The value of their Exxon Mobil holdings saw a notable rise from $4,864,000 in Q2 to $5,803,000 in Q3, reflecting a significant 19.3% increase. This change showcases Summit Financial Group's bullish stance on the energy sector and their trust in Exxon Mobil's future growth potential.

These insights into Summit Financial Group's Q2 and Q3 13F holdings comparison provide a glimpse into the investment decisions made by the company during this period. While there were some decreases in holdings, these adjustments are part of a dynamic investment strategy that aims to optimize returns and manage risk effectively. By analyzing these changes, investors can gain valuable insights into the current market trends and make informed investment decisions.

Disclaimer: The information provided in this article is for informational purposes only and should not be regarded as financial advice. It is essential to conduct thorough research and seek professional guidance before making any investment decisions.